Testing SGC001 for anterior wall heart attack
Part of Heart & circulation clinical trials.
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 79 years old.
- You are having a specific type of heart attack called anterior ST-elevation myocardial infarction (STEMI), with chest pain lasting more than 30 minutes and certain ECG changes.
- You are scheduled to have a procedure (primary PCI) to open the blocked artery.
- You can receive the study drug within 6 hours of when your chest pain started.
- You do not have any of the excluded heart conditions, such as a previous heart attack, prior heart procedures, certain heart rhythm problems, or severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of placing a stent in a blocked heart artery after a recent heart attack. One method uses a special ultrasound called IVUS to guide placement, while the other uses standard X-ray imaging. The goal is to see which one leads to better recovery and fewer complications.
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
This trial tests whether using a special device to remove blood clots during emergency heart artery opening can improve outcomes for people having a major heart attack on the front of the heart. It is for patients who get to the hospital quickly after symptoms start.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This study tests a new magnetic heart scan (MCG) to see if it can better detect blocked arteries causing chest pain or heart attacks. It may help doctors decide the best treatment for you.
Hear when a new Acute Anterior ST-Segment Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.